BioInsights - Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture - spotlight

CELL & GENE THERAPY INSIGHTS

Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

Jan Thirkettle

Guest Editor:

Jan Thirkettle, Chief Executive Officer at Transine Therapeutics

September 2020

Download full spotlight

TESSA technology: a new paradigm in AAV manufacturing

R Cawood

1 October 2020

FastFacts

Read more
Scalable and efficient AAV production process with new Fibro chromatography technology

L Adamson-Small,

M Lundgren,

P Guterstam

30 September 2020

Innovator Insight

Read more
Delivering cell and gene therapies: evolving logistics considerations

A Lee-Mohan,

D Murphy

29 September 2020

Interview

Read more
A necessary transition: why viral vector production for gene therapy needs to evolve

R Cawood

29 September 2020

Interview

Read more
Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them

H Brahmbhatt,

T Guarinoni,

E Simmons

29 September 2020

Expert Roundtable

Read more
Delivering cell and gene therapies: evolving logistics considerations - Podcast

A Lee-Mohan,

D Murphy

29 September 2020

Podcast

Listen now
Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

J Thirkettle

29 September 2020

Foreword

Read more
The power of small: success of small academic/healthcare units within the cell & gene therapy industry

B Weil,

O Bain

24 September 2020

Commentary

Read more
Driving NK cell therapy manufacture to commercial scale

L Sender

23 September 2020

Interview

Read more
Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them

H Brahmbhatt,

T Guarinoni,

E Simmons

21 September 2020

Expert Roundtable Video

Watch now
Small labels, big challenges: solutions for advanced therapy labeling

H Hagen,

C Suchet

21 September 2020

Commentary

Read more
Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools

A Katragadda,

I Karimi,

X Wang

3 September 2020

Expert Insight

Read more
The multi-modal manufacturing movement - you don't need to know the future to be ready for it

Peter Walters, ATMP Conceptual Designer at CRB

Noel Maestre, Director, ATMP at CRB

30 September 2020

Webinar

Watch now
Get your assay in gear – removing analytical bottlenecks on the path to clinical readiness

Ian Gaudet, Senior Director of Process Sciences at Miltenyi Biotec

8 September 2020

Webinar

Watch now
Realizing flexible automation – Closing gaps to meet industry needs

Knut Niss, CTO at Mustang Bio, Inc.

Steven Thompson, Director, Sales & Product Management at Sexton Biotechnologies

Mark Lowdell, Professor of Cell & Tissue Therapy at Royal Free London NHS Foundation Trust

12 August 2020

Webinar

Watch now
Size matters: ensuring donor pool sustainability and cell therapy supply chain success when scaling up and out

Chris Learn, Senior Director - Therapeutic Strategy Lead, Cell & Gene Therapy at IQVIA

Amit Agarwal, Managing Director at Deloitte Consulting

Raymond Hornung, Senior Manager, Logistics at Be The Match BioTherapies

6 August 2020

Webinar

Watch now
Scalable and efficient AAV production process with new Fibro chromatography technology

Laura Adamson-Small, Upstream & Analytical Development Lead, AAV Process Development at UCB Pharma

Mats Lundgren, Customer Applications Director, Life Sciences, Cytiva

Peter Guterstam, Product Manager, Next Generation Resins & Technologies, Cytiva

30 July 2020

Webinar

Watch now